BMS-986251
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BMS-986251, covering 2019-10-21 to 2019-10-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis [Phase 1, Phase 2]